A detailed history of Investment House LLC transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Investment House LLC holds 99,976 shares of INDP stock, worth $99,976. This represents 0.01% of its overall portfolio holdings.

Number of Shares
99,976
Previous 102,437 2.4%
Holding current value
$99,976
Previous $217,000 43.32%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$1.13 - $2.25 $2,780 - $5,537
-2,461 Reduced 2.4%
99,976 $123,000
Q4 2023

Feb 05, 2024

SELL
$1.75 - $2.75 $721 - $1,133
-412 Reduced 0.4%
102,437 $180,000
Q3 2023

Nov 09, 2023

SELL
$1.75 - $3.95 $9,507 - $21,460
-5,433 Reduced 5.02%
102,849 $282,000
Q2 2023

Aug 08, 2023

BUY
$1.6 - $3.04 $20,244 - $38,465
12,653 Added 13.23%
108,282 $206,000
Q4 2021

Feb 09, 2022

BUY
$5.21 - $7.93 $364,574 - $554,909
69,976 Added 272.78%
95,629 $545,000
Q3 2021

Nov 12, 2021

BUY
$7.07 - $14.84 $181,366 - $380,690
25,653 New
25,653 $201,000

Others Institutions Holding INDP

About Indaptus Therapeutics, Inc.


  • Ticker INDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,258,600
  • Market Cap $8.26M
  • Description
  • Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...
More about INDP
Track This Portfolio

Track Investment House LLC Portfolio

Follow Investment House LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment House LLC with notifications on news.